An Enhanced Recovery after Surgery Pathway for Microvascular Breast Reconstruction Is Safe and Effective

Background:. The aim of this study was to develop, implement, and evaluate a standardized perioperative enhanced recovery after surgery (ERAS) clinical care pathway in microsurgical abdominal-based breast reconstruction. Methods:. Development of a clinical care pathway was informed by the latest ERA...

Full description

Bibliographic Details
Main Authors: Arezoo Astanehe, MD, MSc, PhD, Claire Temple-Oberle, MD, MSc, Markus Nielsen, William de Haas, MD, Robert Lindsay, MD, Jennifer Matthews, MD, David C McKenzie, MD, Justin Yeung, MD, Christiaan Schrag, MD
Format: Article
Language:English
Published: Wolters Kluwer 2018-01-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000001634
_version_ 1828976109064028160
author Arezoo Astanehe, MD, MSc, PhD
Claire Temple-Oberle, MD, MSc
Markus Nielsen
William de Haas, MD
Robert Lindsay, MD
Jennifer Matthews, MD
David C McKenzie, MD
Justin Yeung, MD
Christiaan Schrag, MD
author_facet Arezoo Astanehe, MD, MSc, PhD
Claire Temple-Oberle, MD, MSc
Markus Nielsen
William de Haas, MD
Robert Lindsay, MD
Jennifer Matthews, MD
David C McKenzie, MD
Justin Yeung, MD
Christiaan Schrag, MD
author_sort Arezoo Astanehe, MD, MSc, PhD
collection DOAJ
description Background:. The aim of this study was to develop, implement, and evaluate a standardized perioperative enhanced recovery after surgery (ERAS) clinical care pathway in microsurgical abdominal-based breast reconstruction. Methods:. Development of a clinical care pathway was informed by the latest ERAS guideline for breast reconstruction. Key features included shortened preoperative fasting, judicious fluids, multimodal analgesics, early oral nutrition, early Foley catheter removal, and early ambulation. There were 3 groups of women in this cohort study: (1) traditional historical control; (2) transition group with partial implementation; and (3) ERAS. Narcotic use, patient-reported pain scores, antiemetic use, time to regular diet, time to first walk, hospital length of stay, and 30-day postoperative complications were compared between the groups. Results:. After implementation of the pathway, the use of parenteral narcotics was reduced by 88% (traditional, 112 mg; transition, 58 mg; ERAS, 13 mg; P < 0.0001), with no consequent increase in patient-reported pain. Patients in the ERAS cohort used less antiemetics (7.0, 5.3, 2.2 doses, P < 0.0001), returned to normal diet 19 hours earlier (46, 39, 27 hours, P < 0.0001), and walked 25 hours sooner (75, 70, 50 hours, P < 0.0001). Overall, hospital length of stay was reduced by 2 days in the ERAS cohort (6.6, 5.6, 4.8 days, P < 0.0001), without an increase in rates of major complications (9.5%, 10.1%, 8.3%, P = 0.9). Conclusions:. A clinical care pathway in microsurgical breast reconstruction using the ERAS Society guideline promotes successful early recovery.
first_indexed 2024-12-14T14:32:31Z
format Article
id doaj.art-591e02a229914fc0aeadccdd4f158702
institution Directory Open Access Journal
issn 2169-7574
language English
last_indexed 2024-12-14T14:32:31Z
publishDate 2018-01-01
publisher Wolters Kluwer
record_format Article
series Plastic and Reconstructive Surgery, Global Open
spelling doaj.art-591e02a229914fc0aeadccdd4f1587022022-12-21T22:57:46ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742018-01-0161e163410.1097/GOX.0000000000001634201801000-00001An Enhanced Recovery after Surgery Pathway for Microvascular Breast Reconstruction Is Safe and EffectiveArezoo Astanehe, MD, MSc, PhD0Claire Temple-Oberle, MD, MSc1Markus Nielsen2William de Haas, MD3Robert Lindsay, MD4Jennifer Matthews, MD5David C McKenzie, MD6Justin Yeung, MD7Christiaan Schrag, MD8From the Division of Plastic and Reconstructive Surgery, University of Calgary, Calgary, Alberta, Canada.From the Division of Plastic and Reconstructive Surgery, University of Calgary, Calgary, Alberta, Canada.From the Division of Plastic and Reconstructive Surgery, University of Calgary, Calgary, Alberta, Canada.From the Division of Plastic and Reconstructive Surgery, University of Calgary, Calgary, Alberta, Canada.From the Division of Plastic and Reconstructive Surgery, University of Calgary, Calgary, Alberta, Canada.From the Division of Plastic and Reconstructive Surgery, University of Calgary, Calgary, Alberta, Canada.From the Division of Plastic and Reconstructive Surgery, University of Calgary, Calgary, Alberta, Canada.From the Division of Plastic and Reconstructive Surgery, University of Calgary, Calgary, Alberta, Canada.From the Division of Plastic and Reconstructive Surgery, University of Calgary, Calgary, Alberta, Canada.Background:. The aim of this study was to develop, implement, and evaluate a standardized perioperative enhanced recovery after surgery (ERAS) clinical care pathway in microsurgical abdominal-based breast reconstruction. Methods:. Development of a clinical care pathway was informed by the latest ERAS guideline for breast reconstruction. Key features included shortened preoperative fasting, judicious fluids, multimodal analgesics, early oral nutrition, early Foley catheter removal, and early ambulation. There were 3 groups of women in this cohort study: (1) traditional historical control; (2) transition group with partial implementation; and (3) ERAS. Narcotic use, patient-reported pain scores, antiemetic use, time to regular diet, time to first walk, hospital length of stay, and 30-day postoperative complications were compared between the groups. Results:. After implementation of the pathway, the use of parenteral narcotics was reduced by 88% (traditional, 112 mg; transition, 58 mg; ERAS, 13 mg; P < 0.0001), with no consequent increase in patient-reported pain. Patients in the ERAS cohort used less antiemetics (7.0, 5.3, 2.2 doses, P < 0.0001), returned to normal diet 19 hours earlier (46, 39, 27 hours, P < 0.0001), and walked 25 hours sooner (75, 70, 50 hours, P < 0.0001). Overall, hospital length of stay was reduced by 2 days in the ERAS cohort (6.6, 5.6, 4.8 days, P < 0.0001), without an increase in rates of major complications (9.5%, 10.1%, 8.3%, P = 0.9). Conclusions:. A clinical care pathway in microsurgical breast reconstruction using the ERAS Society guideline promotes successful early recovery.http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000001634
spellingShingle Arezoo Astanehe, MD, MSc, PhD
Claire Temple-Oberle, MD, MSc
Markus Nielsen
William de Haas, MD
Robert Lindsay, MD
Jennifer Matthews, MD
David C McKenzie, MD
Justin Yeung, MD
Christiaan Schrag, MD
An Enhanced Recovery after Surgery Pathway for Microvascular Breast Reconstruction Is Safe and Effective
Plastic and Reconstructive Surgery, Global Open
title An Enhanced Recovery after Surgery Pathway for Microvascular Breast Reconstruction Is Safe and Effective
title_full An Enhanced Recovery after Surgery Pathway for Microvascular Breast Reconstruction Is Safe and Effective
title_fullStr An Enhanced Recovery after Surgery Pathway for Microvascular Breast Reconstruction Is Safe and Effective
title_full_unstemmed An Enhanced Recovery after Surgery Pathway for Microvascular Breast Reconstruction Is Safe and Effective
title_short An Enhanced Recovery after Surgery Pathway for Microvascular Breast Reconstruction Is Safe and Effective
title_sort enhanced recovery after surgery pathway for microvascular breast reconstruction is safe and effective
url http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000001634
work_keys_str_mv AT arezooastanehemdmscphd anenhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT clairetempleoberlemdmsc anenhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT markusnielsen anenhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT williamdehaasmd anenhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT robertlindsaymd anenhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT jennifermatthewsmd anenhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT davidcmckenziemd anenhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT justinyeungmd anenhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT christiaanschragmd anenhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT arezooastanehemdmscphd enhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT clairetempleoberlemdmsc enhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT markusnielsen enhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT williamdehaasmd enhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT robertlindsaymd enhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT jennifermatthewsmd enhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT davidcmckenziemd enhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT justinyeungmd enhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective
AT christiaanschragmd enhancedrecoveryaftersurgerypathwayformicrovascularbreastreconstructionissafeandeffective